ORINY – orion corp new unsp/adr (US:NASDAQ)

News

Bayer Submits Supplemental New Drug Application to U.S. FDA Seeking Expanded Indication for NUBEQA® (darolutamide) in Metastatic Hormone-Sensitive Prostate Cancer [Yahoo! Finance]
Orion’s collaboration partner Bayer submits application to U.S. FDA for third indication of darolutamide which has become the first ever Orion-originated blockbuster
Orion and Aitia enter AI-Driven Drug Discovery and Drug Simulation Collaboration in Oncology
213,285 Orion Corporation A shares converted into B shares [Yahoo! Finance]
Inside information: Orion upgrades full-year outlook for 2024 [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com